Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Cutanogen Inc
Profile last edited on: 1/17/19      CAGE:       UEI:

Business Identifier: Wound treatments
Year Founded
1990
First Award
1993
Latest Award
2000
Program Status
Inactive (Acquired)
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

31 Bishops Lane
Sudbury, MA 01776
   (508) 443-8208
   bapi@bu.edu
   N/A
Location: Single
Congr. District: 05
County: Middlesex

Public Profile

In February 2006, Cambrex bought the wound treatment SBIR awardee Cutanogen Inc for $1.5mm plus additional $4.8mm in regulatory and commercial earn-outs. Later that same year (October 2006) the Swiss firm Lonza bought Cambrex bioproducts and biopharma businesses. Hence, Cutanogen Inc is now a division of Lonza Group Ltd.

Extent of SBIR involvement

User Avatar
Phase I Awards
3
Phase II Awards
1
Conversion Rate
33.33%
Phase I Dollars
$303,126
Phase II Dollars
$571,556
Total Awarded
$874,682

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2000 2 NIH $671,556
Project Title: Therapy For Chemotherapy Alopecia With PTHRP Analogs
2000 1 NIH $153,126
Project Title: Treatment of Psoriasis with Parathyroid Hormone
1993 1 NIH $50,000
Project Title: Synthesis and evaluation of 1,25(OH)2D3-glycosides

Key People / Management

  Robert Burr

  Rahul Ray

Company News

There are no news available.